A Multicenter Cancer Biospecimen Collection Study
NCT04510129
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This study will collect de-identified tumor samples, with correlated clinical/demographic data and tissue histology, from patients selected or scheduled for pre-treatment tumor biopsy or who have had a recent pre-treatment tumor biopsy. These specimens and clinical data may be used in subsequent studies for the development and validation of a diagnostic test.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Cancer of Head and Neck
- Lung Cancer, Nonsmall Cell
- Small-cell Lung Cancer
- Urothelial Carcinoma
- Gastroesophageal Junction Adenocarcinoma
- Cervical Cancer
- Esophageal Squamous Cell Carcinoma
- Triple Negative Breast Cancer
- Hepatocellular Carcinoma
- Renal Cell Carcinoma
- Colorectal Cancer
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Cofactor Genomics, Inc.
- Last updated on ClinicalTrials.gov
- March 12, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Curebase · San Francisco, CA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.